Cargando…

Healthcare Costs Before and After Diagnosis of Cancer of Unknown Primary Versus Ovarian Cancer in Australia

BACKGROUND: Little is known about the healthcare resource usage and costs for patients with cancer of unknown primary (CUP). OBJECTIVE: The aim of this study was to describe and quantify healthcare resource use and costs in Australia, 6 months prior to and after a diagnosis of CUP, and compare to th...

Descripción completa

Detalles Bibliográficos
Autores principales: Gordon, Louisa G., Wood, C., Tothill, R. W., Webb, P. M., Schofield, P., Mileshkin, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929003/
https://www.ncbi.nlm.nih.gov/pubmed/36253664
http://dx.doi.org/10.1007/s41669-022-00371-1
_version_ 1784888753808998400
author Gordon, Louisa G.
Wood, C.
Tothill, R. W.
Webb, P. M.
Schofield, P.
Mileshkin, L.
author_facet Gordon, Louisa G.
Wood, C.
Tothill, R. W.
Webb, P. M.
Schofield, P.
Mileshkin, L.
author_sort Gordon, Louisa G.
collection PubMed
description BACKGROUND: Little is known about the healthcare resource usage and costs for patients with cancer of unknown primary (CUP). OBJECTIVE: The aim of this study was to describe and quantify healthcare resource use and costs in Australia, 6 months prior to and after a diagnosis of CUP, and compare to those of women with ovarian cancer. METHODS: Individual-level data combining baseline surveys, clinical records and Medicare Benefits Schedule (MBS) claim records were analysed for 149 patients with CUP and 480 patients with ovarian cancer from two prospective cohort studies. MBS data were aggregated for the period 6 months prior to diagnosis date and 6 months after diagnosis. Data included doctor consultations, pathology, diagnostics, therapeutic procedures, imaging, allied health and medicines. Generalised linear models were used to evaluate the cost differences between CUP and ovarian cancer using gamma family and log link functions. Models were adjusted for age, employment, marital status, surgery, chemotherapy and number of comorbidities. RESULTS: The mean healthcare costs in the 6 months prior to diagnosis of CUP were Australian (AU) $3903 versus AU$1327 for ovarian cancer (adjusted cost ratio 2.94, 95% confidence interval [CI] 2.08–4.15). Mean healthcare costs 6 months post-diagnosis were higher for patients with CUP versus ovarian cancer (AU$20,339 vs AU$13,819, adjusted cost ratio 1.47, 95% CI 1.13–1.92). Higher costs for patients with CUP were driven by imaging (AU$1937 vs AU$1387), procedures (AU$5403 vs AU$2702) and prescribed medicines for all conditions (AU$10,111 vs AU$6717). CONCLUSIONS: Pre-diagnosis costs for patients with CUP are nearly triple those for ovarian cancer. Six months after diagnosis, healthcare costs for CUP remained higher than for ovarian cancer due to imaging, procedures and medicines. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s41669-022-00371-1.
format Online
Article
Text
id pubmed-9929003
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-99290032023-02-16 Healthcare Costs Before and After Diagnosis of Cancer of Unknown Primary Versus Ovarian Cancer in Australia Gordon, Louisa G. Wood, C. Tothill, R. W. Webb, P. M. Schofield, P. Mileshkin, L. Pharmacoecon Open Original Research Article BACKGROUND: Little is known about the healthcare resource usage and costs for patients with cancer of unknown primary (CUP). OBJECTIVE: The aim of this study was to describe and quantify healthcare resource use and costs in Australia, 6 months prior to and after a diagnosis of CUP, and compare to those of women with ovarian cancer. METHODS: Individual-level data combining baseline surveys, clinical records and Medicare Benefits Schedule (MBS) claim records were analysed for 149 patients with CUP and 480 patients with ovarian cancer from two prospective cohort studies. MBS data were aggregated for the period 6 months prior to diagnosis date and 6 months after diagnosis. Data included doctor consultations, pathology, diagnostics, therapeutic procedures, imaging, allied health and medicines. Generalised linear models were used to evaluate the cost differences between CUP and ovarian cancer using gamma family and log link functions. Models were adjusted for age, employment, marital status, surgery, chemotherapy and number of comorbidities. RESULTS: The mean healthcare costs in the 6 months prior to diagnosis of CUP were Australian (AU) $3903 versus AU$1327 for ovarian cancer (adjusted cost ratio 2.94, 95% confidence interval [CI] 2.08–4.15). Mean healthcare costs 6 months post-diagnosis were higher for patients with CUP versus ovarian cancer (AU$20,339 vs AU$13,819, adjusted cost ratio 1.47, 95% CI 1.13–1.92). Higher costs for patients with CUP were driven by imaging (AU$1937 vs AU$1387), procedures (AU$5403 vs AU$2702) and prescribed medicines for all conditions (AU$10,111 vs AU$6717). CONCLUSIONS: Pre-diagnosis costs for patients with CUP are nearly triple those for ovarian cancer. Six months after diagnosis, healthcare costs for CUP remained higher than for ovarian cancer due to imaging, procedures and medicines. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s41669-022-00371-1. Springer International Publishing 2022-10-17 /pmc/articles/PMC9929003/ /pubmed/36253664 http://dx.doi.org/10.1007/s41669-022-00371-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research Article
Gordon, Louisa G.
Wood, C.
Tothill, R. W.
Webb, P. M.
Schofield, P.
Mileshkin, L.
Healthcare Costs Before and After Diagnosis of Cancer of Unknown Primary Versus Ovarian Cancer in Australia
title Healthcare Costs Before and After Diagnosis of Cancer of Unknown Primary Versus Ovarian Cancer in Australia
title_full Healthcare Costs Before and After Diagnosis of Cancer of Unknown Primary Versus Ovarian Cancer in Australia
title_fullStr Healthcare Costs Before and After Diagnosis of Cancer of Unknown Primary Versus Ovarian Cancer in Australia
title_full_unstemmed Healthcare Costs Before and After Diagnosis of Cancer of Unknown Primary Versus Ovarian Cancer in Australia
title_short Healthcare Costs Before and After Diagnosis of Cancer of Unknown Primary Versus Ovarian Cancer in Australia
title_sort healthcare costs before and after diagnosis of cancer of unknown primary versus ovarian cancer in australia
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929003/
https://www.ncbi.nlm.nih.gov/pubmed/36253664
http://dx.doi.org/10.1007/s41669-022-00371-1
work_keys_str_mv AT gordonlouisag healthcarecostsbeforeandafterdiagnosisofcancerofunknownprimaryversusovariancancerinaustralia
AT woodc healthcarecostsbeforeandafterdiagnosisofcancerofunknownprimaryversusovariancancerinaustralia
AT tothillrw healthcarecostsbeforeandafterdiagnosisofcancerofunknownprimaryversusovariancancerinaustralia
AT webbpm healthcarecostsbeforeandafterdiagnosisofcancerofunknownprimaryversusovariancancerinaustralia
AT schofieldp healthcarecostsbeforeandafterdiagnosisofcancerofunknownprimaryversusovariancancerinaustralia
AT mileshkinl healthcarecostsbeforeandafterdiagnosisofcancerofunknownprimaryversusovariancancerinaustralia
AT healthcarecostsbeforeandafterdiagnosisofcancerofunknownprimaryversusovariancancerinaustralia